High Grade Meningioma
5 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Phase II Trial of Pembrolizumab in Recurrent or Residual High Grade Meningioma (NCT03279692) | Massachusetts General Hospital | 2017-11-07 |
| Rare CNS Tumors Outcomes &Risk (NCT03251989) | National Cancer Institute (NCI) | 2017-08-21 |
| Panobinostat and Stereotactic Radiation Therapy in Treating Patients With Brain Tumors (NCT01324635) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2012-05-01 |
Track High Grade Meningioma automatically
Every clearance here is in the API, with alerts when new ones post.